文献速递角膜与眼表疾病

干眼病与血脂异常及他汀类药物使用的关联

Association of Dry Eye Disease With Dyslipidemia and Statin Use.
PubMed 文献 · Am J Ophthalmol · 2020-05-12

这项回顾性病例对照研究分析了北卡罗来纳大学眼科诊所10年间的39,336例患者,发现他汀类药物使用史和血脂异常均与干眼病诊断的比值比升高相关,提示两者可能是干眼病的相关因素。

要点

  • 低、中、高强度他汀使用与干眼病诊断的OR分别为1.39、1.47、1.46。
  • 总胆固醇>200 mg/dL、HDL<40 mg/dL、LDL>130 mg/dL、TG>150 mg/dL均与干眼病诊断OR升高相关。
  • 研究为回顾性设计,不能确定他汀或血脂异常是否增加干眼病风险。

核心结论

  • 他汀类药物使用史或血脂异常与干眼病诊断的比值比升高相关。
  • 需进一步研究确定他汀使用和/或血脂异常是否增加干眼病风险。

研究设计与样本

  • 回顾性病例对照研究,设置于北卡罗来纳大学附属医疗机构。
  • 研究人群为10年间在该眼科诊所就诊的72,931例患者,排除干眼病混杂危险因素后分析39,336例(53.9%女性)。

主要发现

  • 3,399例(8.6%)携带干眼病诊断。
  • 低、中、高强度他汀使用分别为751例(1.9%)、2,655例(6.8%)、1,036例(2.6%)。
  • 总胆固醇>200 mg/dL者4,558例(11.6%),HDL<40 mg/dL者2,078例(5.3%),LDL>130 mg/dL者2,756例(7.0%),TG>150 mg/dL者2,881例(7.3%)。
  • 低、中、高强度他汀使用与干眼病诊断的OR分别为1.39(95%CI 1.13-1.72)、1.47(95%CI 1.30-1.65)、1.46(95%CI 1.21-1.75)。
  • 总胆固醇>200 mg/dL、HDL<40 mg/dL、LDL>130 mg/dL、TG>150 mg/dL与干眼病诊断的OR分别为1.66(95%CI 1.52-1.82)、1.45(95%CI 1.26-1.67)、1.55(95%CI 1.39-1.74)、1.43(95%CI 1.27-1.61)。

关键数值与推荐

  • 血脂异常定义:总胆固醇>200 mg/dL,HDL<40 mg/dL,LDL>130 mg/dL,TG>150 mg/dL。
  • 他汀强度分为低、中、高三个等级,具体剂量标准原文未报告。

临床怎么用

  • 对干眼病患者可关注他汀使用史和血脂异常情况,但当前证据仅为关联性,不能推断因果。
  • 他汀使用或血脂异常不应作为干眼病的独立诊断依据,需结合临床综合评估。

局限性

  • 回顾性病例对照设计,无法确定他汀使用或血脂异常与干眼病的因果关系。
  • 原文未报告他汀强度定义的具体剂量标准及其他潜在混杂因素的控制情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether an association exists between dry eye disease (DED) and statin use and/or dyslipidemia. DESIGN: Retrospective, case-control study. METHODS: Setting: University of North Carolina (UNC)-affiliated healthcare facilities. STUDY POPULATION: 72,931 patients seen at UNC ophthalmology clinics over a 10-year period. MAIN OUTCOME MEASURES: Odds ratios (ORs) calculated between DED and a history of low, moderate, or high-intensity statin use; and ORs calculated between DED and abnormal lipid panel values. RESULTS: Total of 39,336 individuals (53.9% female) were analyzed after exclusion of individuals with confounding risk factors for DED. Of these, 3,399 patients (8.6%) carried a diagnosis of DED. Low-, moderate-, and high-intensity statin regimens were used by 751 subjects (1.9%), 2,655 subjects (6.8%), and 1,036 subjects (2.6%). Lipid abnormalities were identified as total cholesterol >200 mg/dL, 4,558 subjects (11.6%); high-density lipoprotein (HDL) <40 mg/dL, 2,078 subjects (5.3%); low-density lipoprotein (LDL) >130 mg/dL, 2,756 subjects (7.0%); and triglycerides (TGs) >150 mg/dL, 2,881 subjects (7.3%). The odds ratios (OR) of carrying a diagnosis of DED given the presence of low-, moderate-, and high-intensity statin use were 1.39 (95% confidence interval [CI]: 1.13-1.72); OR 1.47 (95% CI: 1.30-1.65), and OR 1.46 (95% CI: 1.21-1.75), respectively. The OR of carrying a diagnosis of DED given the presence of total cholesterol >200 mg/dL, HDL <40 mg/dL, LDL >130 mg/dL, and TGs >150 mg/dL were 1.66 (95% CI: 1.52-1.82), 1.45 (95% CI: 1.26-1.67), 1.55 (95% CI: 1.39-1.74), and 1.43 (95% CI: 1.27-1.61), respectively. CONCLUSIONS: A history of statin use or dyslipidemia is associated with an increased odds of having a DED diagnosis. Further studies are needed to determine whether statin use and/or dyslipidemia increases the risk of DED.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Aldaas KM, Ismail OM, Hakim J, et al. Association of Dry Eye Disease With Dyslipidemia and Statin Use. Am J Ophthalmol. 2020. PMID: 32413410. doi:10.1016/j.ajo.2020.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。